Literature DB >> 8279094

The effects of citrate and urine on calcium oxalate crystal aggregation.

H G Tiselius1, A M Fornander, M A Nilsson.   

Abstract

The rate of crystal sedimentation in a suspension of calcium oxalate monohydrate (COM) crystals was determined spectrophotometrically in the presence and absence of dialysed urine and citrate. A reduced rate of crystal sedimentation after stirring was recorded in suspensions containing citrate in concentrations between 0.33 and 1.67 mmol/l. The sedimentation rate was reduced in the presence of a 0.3-3.3% concentration of dialysed urine, with increased inhibition of crystal sedimentation when the concentration of urine was increased. A comparison of the inhibition of COM crystal sedimentation in whole urine and in dialysed urine from normal subjects and stone-formers disclosed significantly higher values (P < 0.05) in the dialysed urine. The results support previous observations that physiological concentrations of citrate might efficiently inhibit the aggregation of COM crystals. Furthermore even low concentrations of both whole urine and dialysed urine are apparently very efficient inhibitors of COM crystal aggregation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8279094     DOI: 10.1007/bf00296838

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  12 in total

Review 1.  Protein inhibitors of crystallization.

Authors:  F I Coe; J H Parks; Y Nakagawa
Journal:  Semin Nephrol       Date:  1991-03       Impact factor: 5.299

2.  Citrate and renal calculi: new insights and future directions.

Authors:  C Y Pak
Journal:  Am J Kidney Dis       Date:  1991-04       Impact factor: 8.860

3.  Long-term treatment of calcium nephrolithiasis with potassium citrate.

Authors:  C Y Pak; C Fuller; K Sakhaee; G M Preminger; F Britton
Journal:  J Urol       Date:  1985-07       Impact factor: 7.450

4.  Crystal agglomeration is a major element in calcium oxalate urinary stone formation.

Authors:  D J Kok; S E Papapoulos; O L Bijvoet
Journal:  Kidney Int       Date:  1990-01       Impact factor: 10.612

5.  Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.

Authors:  B Hess; Y Nakagawa; F L Coe
Journal:  Am J Physiol       Date:  1989-07

6.  Citrate in daily and fasting urine: results of controls, patients with recurrent idiopathic calcium urolithiasis, and primary hyperparathyroidism.

Authors:  P O Schwille; D Scholz; M Paulus; W Engelhardt; A Sigel
Journal:  Invest Urol       Date:  1979-05

Review 7.  Rational prevention of calcium urolithiasis.

Authors:  M Butz
Journal:  Urol Int       Date:  1986       Impact factor: 2.089

Review 8.  Effects of citrate on the different phases of calcium oxalate crystallization.

Authors:  H G Tiselius; C Berg; A M Fornander; M A Nilsson
Journal:  Scanning Microsc       Date:  1993-03

9.  The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis.

Authors:  K Sakhaee; J R Poindexter; C Y Pak
Journal:  J Urol       Date:  1989-04       Impact factor: 7.450

10.  The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation.

Authors:  C Berg; L Larsson; H G Tiselius
Journal:  J Urol       Date:  1992-09       Impact factor: 7.450

View more
  7 in total

1.  Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.

Authors:  Shameez Allie-Hamdulay; Allen L Rodgers
Journal:  Urol Res       Date:  2005-05-04

2.  Is citrate an inhibitor of calcium oxalate crystal growth in high concentrations of urine?

Authors:  H Bek-Jensen; A M Fornander; M A Nilsson; H G Tiselius
Journal:  Urol Res       Date:  1996

3.  Oxalate and its handling in a low stone risk vs a stone-prone population group.

Authors:  Sonja Lewandowski; Allen L Rodgers; Norbert Laube; Gerd von Unruh; Diana Zimmermann; Albrecht Hesse
Journal:  World J Urol       Date:  2005-11-06       Impact factor: 4.226

4.  Concentrated urine and diluted urine: the effects of citrate and magnesium on the crystallization of calcium oxalate induced in vitro by an oxalate load.

Authors:  Angela Guerra; Tiziana Meschi; Franca Allegri; Beatrice Prati; Antonio Nouvenne; Enrico Fiaccadori; Loris Borghi
Journal:  Urol Res       Date:  2006-12

Review 5.  Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.

Authors:  Helene Jung; Sero Andonian; Dean Assimos; Timothy Averch; Petrisor Geavlete; Yasuo Kohjimoto; Andreas Neisius; Joe Philip; Alberto Saita; Hemendra Shah; Palle Jörn Osther
Journal:  World J Urol       Date:  2017-02-03       Impact factor: 4.226

6.  Oxalate synthesis from hydroxypyruvate in vitamin-B6-deficient rats.

Authors:  Yaovalak Teerajetgul; Rayhan Zubair Hossain; Kenichi Yamakawa; Makoto Morozumi; Kimio Sugaya; Yoshihide Ogawa
Journal:  Urol Res       Date:  2007-06-13

7.  Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults.

Authors:  C Guittet; C Roussel-Maupetit; M A Manso-Silván; F Guillaumin; F Vandenhende; L A Granier
Journal:  Sci Rep       Date:  2020-08-18       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.